Skip to content
Recall Observatory FDA recall evidence

Drug product

MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05

D-0456-2017

December 16, 2016

Class II

Product summary

Firm
Fresenius Kabi USA, LLC
Event
Event 76001
Status
Terminated
Classification
Class II
Quantity
47, 020 vials
Official record key
drug-enforcement:D-0456-2017

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot 6007327, exp. 01-2017; Lot 6007329, exp. 01-2017

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications